Hero background pattern

From launching your product to training your team

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

Launch implementation

Develop and implement a pricing and market access launch strategy for your product

Learn more

Price Optimization

Having the right pharma pricing strategy is essential for your product to optimize revenues.

Learn more

Price & Market Access Training

We aim to make the transfer of knowledge more flexible, effective, and engaging.

Learn more

We work with people who’re asking:

Optimal price
What is the optimal price for our product?
Right evidence
Do we have the right evidence to support price and access to launch?
Training people
Do we have the right capabilities to train people on market access?
Market access potential
What is the pricing and market access potential for BD opportunities?

Discover the latest insights

ISPOR Europe 2023
We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…
Read more
World Orphan Drug Congress Europe 2023 REPORT
We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
NICE’s Proportionate Approach to Technology …
Webinar: Our experts discuss NICE’s proportionate approach to technology appraisals and the implicat…
Read more
ISPOR Europe 2023: Can Just Three PICOs be Feasibl…
This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment…
Read more
ISPOR Europe 2023: How Aware Are Biotech and Pharm…
Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in…
Read more
pharmaceutical law
Germany’s Health Ministry Shifts Focus to Di…
Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de…
Read more
New Additions to HTA International Collaboration
In a ground breaking move, the international collaboration among six prominent health technology ass…
Read more
How to get payer scientific advice between now and…
Our market access experts provide an overview of how to get payer scientific advice between Septembe…
Read more
Spain’s National Court Annuls Proposed Thera…
Spain’s National Court recently invalidated the proposed plan for consolidating therapeutic position…
Read more
PMA Insights: Week 29
We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi…
Read more